(marketscreener.com) Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 14, 2023, Sientra, Inc. received written notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC notifying the Company that, based on the closing bid price of the Company's...https://www.marketscreener.com/quote/stock/SIENTRA-INC-18397158/news/Sientra-Failure-to-Satisfy-Listing-Rule-Form-8-K-45612122/?utm_medium=RSS&utm_content=20231220
Sientra is a California-based medical aesthetics company that develops and commercializes products such as breast implants and tissue expanders for the healthcare industry.